Regulatory execution
A structured pathway from local registration and market access to launch readiness.
Commercialisation & partnerships
Building the next phase with the right partners.
Asamedic works with pharmaceutical and life-science partners to bring Coxor® to more patients and more markets.
Partner-led expansion
Local insight. Global ambition. One protected asset.
Our model combines a central pharmaceutical asset with partners who bring local regulatory, market access, distribution and commercial capabilities.
We are interested in conversations with established pharmaceutical companies and specialised partners who see the opportunity in a differentiated emergency cardiovascular product.
Discuss a marketHow we create value together
Commercial activation
Local partners bring the customer insight, distribution and launch capability required for adoption.
Long-term growth
A partner model designed to support supply, sales, milestones and royalties over time.
Current platform
A growing network around Coxor®.
Aspen Pharma
A strategic partner platform covering European and GCC markets, supporting the next phase of international commercialisation.
Terapia · Sun Pharma
A Romanian market partnership supporting local registration, launch and commercial execution.
Additional territories
Asamedic is developing further market relationships across Europe, the Middle East, Asia and other international territories.
Our partner-led model combines a central pharmaceutical asset with local regulatory, market access, distribution and commercial capabilities.
EUROPENORDICSGCCEASTERN EUROPEASIAEMERGING MARKETS
Start a confidential conversationLicensing opportunity
Is Coxor® relevant for your market?
Tell us where you operate and how you could help accelerate access to early cardiovascular care.
Contact business development